HomeStock ScreenerStar Source Multi Trade

Star Source Multi Trade Current Share Price | Star Source Multi Trade Stock Screener

STARSOURCE Pharmaceuticals
Live Share Price BSE
₹90.46
▼ -3.53 (-3.76%)
2026-08-18 00:00:00
As of August 18, 2026, the live Star Source Multi Trade share price (BSE: STARSOURCE) is ₹90.46, down 3.76% from the previous close, with shares trading between ₹89.31 and ₹95.00 in today's trading session, and a 52-week range of ₹72.68–₹145.75. Analyse STARSOURCE share price charts and track historical price performance. Use the Star Source Multi Trade stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Star Source Multi Trade Market Cap ₹13.44 Cr.
STARSOURCE P/E Ratio (TTM) -
Star Source Multi Trade P/B Ratio 9.95
EPS (TTM) ₹-9.66
Dividend Yield -
Debt to Equity -
STARSOURCE 52 Week High ₹145.75
Star Source Multi Trade 52 Week Low ₹72.68
Operating Margin -
Profit Margin -
STARSOURCE Revenue (TTM) -
EBITDA -
Net Income -
Total Assets ₹4.00
Total Equity ₹4.00

Star Source Multi Trade Current Share Price Chart

Track the current Star Source Multi Trade share price and stock price with an interactive chart. Analyse STARSOURCE price trends, trading volume, historical performance, and volatility across different timeframes — the complete Star Source Multi Trade stock quote in one place.

Star Source Multi Trade Company Profile - Fundamental Screener

Screen Star Source Multi Trade company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for STARSOURCE shares.
Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E
ISIN INE320M01019

Star Source Multi Trade Balance Sheet Screener

Screen STARSOURCE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2016
Assets
Total Assets 4
Current Assets 2
Fixed Assets 0
Liabilities
Total Liabilities 0
Current Liabilities 0
Non-Current Liabilities 0
Shareholders' Equity
Total Equity 4
Share Capital 2
Reserves & Surplus 2

Star Source Multi Trade Income Statement Screener - Profit & Revenue Analysis

Screen Star Source Multi Trade income statement and profit fundamentals. Analyze STARSOURCE quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Star Source Multi Trade share price evaluation.
Item None-None 2016-March
Revenue 0 -1
Expenses 0 0
EBITDA 0 -1
Operating Profit % 0.00% 0.00%
Depreciation 0 0
Interest 0 0
Profit Before Tax 0 -1
Tax 0 0
Net Profit 0 -1
EPS 0.00 -9.66

Star Source Multi Trade Cash Flow Screener - Liquidity Fundamentals

Screen STARSOURCE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2016-March
Operating Activities -2
Investing Activities 2
Financing Activities 0
Net Cash Flow 0

Star Source Multi Trade Shareholding Pattern Screener

See Star Source Multi Trade shareholding pattern with promoter, FII, and DII holdings. Check Star Source Multi Trade promoter holding and ownership changes for STARSOURCE on TickJournal.
Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun
Promoter Holding 27.89% 27.89% 27.89% 27.89% 27.89% 27.89% 27.89% 27.89%
FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.37% 0.37% 0.37% 0.37% 0.37% 0.37% 0.37% 0.37%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 65.82% 65.72% 65.29% 65.77% 65.66% 65.69% 65.61% 65.63%
Other Holding 5.93% 6.03% 6.46% 5.98% 6.09% 6.06% 6.14% 6.12%
Shareholder Count 6,292 6,264 6,510 6,422 6,409 6,360 6,262 6,254

Star Source Multi Trade Share Dividend Screener - Share Yield Analysis

Check Star Source Multi Trade dividend history with payout and yield data. View Star Source Multi Trade dividend details including ex-dates and amounts for STARSOURCE stock.
No dividends declared by Star Source Multi Trade.

Star Source Multi Trade Stock Index Membership

See which indices include Star Source Multi Trade stock. Check STARSOURCE index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Star Source Multi Trade is not part of any tracked indices.
Only major market indices are tracked in our system.

Star Source Multi Trade Market Events Screener - Corporate Actions

Get Star Source Multi Trade corporate actions including splits, bonuses, and buybacks. Check Star Source Multi Trade stock events that may affect STARSOURCE share price.
Announcement Date Record Date Event Type Information Price Impact
2026-08-14 2026-08-14 Quarterly Result Announcement NA 10.70%
2026-05-29 2026-05-29 Quarterly Result Announcement NA -0.22%
2026-02-12 2026-02-12 Quarterly Result Announcement NA -3.50%
2025-11-13 2025-11-13 Quarterly Result Announcement NA 7.76%
2025-09-24 2025-09-24 Annual General Meeting NA -13.88%
2025-09-24 2025-09-24 Change Of Name NA 0.00%
2025-08-12 2025-08-12 Quarterly Result Announcement NA 11.63%
2025-05-29 2025-05-29 Quarterly Result Announcement NA 18.64%
2025-01-27 2025-01-27 Quarterly Result Announcement NA -12.17%
2024-10-28 2024-10-28 Quarterly Result Announcement NA -7.07%
2024-09-23 2024-09-23 Annual General Meeting NA -5.56%

Star Source Multi Trade Competitors Screener - Peer Comparison

Screen STARSOURCE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 463,072 38.47 61,674 12.69% 11,565 47.09
Divis Laboratories 225,038 77.15 11,067 13.95% 2,568 71.85
Torrent Pharmaceuticals 183,832 86.03 13,886 20.34% 2,138 45.42
Cipla 117,138 35.17 29,045 2.24% 3,870 50.74
Zydus Life Science 114,228 25.48 27,658 17.64% 5,026 50.68
Lupin 102,191 18.62 29,039 26.75% 5,356 30.04
Dr Reddys Laboratories 100,160 31.62 35,059 3.90% 4,158 49.18
Mankind Pharma 100,160 48.30 14,636 14.85% 1,938 43.34
Laurus Labs 96,489 91.23 6,868 22.01% 890 61.64
Aurobindo Pharma 93,332 25.93 34,145 5.56% 3,503 55.68

Star Source Multi Trade Company Announcements - News Screener

Screen STARSOURCE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-17 Unaudited Financial Result For The Quarter Ended On June 30 2026 -
2026-08-17 Board Meeting Outcome for Board Meeting Held On August 14 2026. -
2026-08-15 Board Meeting Intimation for Considering Unaudited Financial Results For The Quarter Ended On June 30 2026. -
2026-07-16 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-06-30 Closure of Trading Window -
2026-05-30 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-05-29 Result-Audited Financial Result For The Fourth Quarter And Year Ended On March 31 2026. -
2026-05-29 Board Meeting Outcome for Outcome Of Board Meeting Held On May 29 2026 -
2026-05-25 Board Meeting Intimation for Considering Audited Financial Results For The Fourth Quarter And Financial Year Ended March 31 2026 Along With The Auditors Report Thereon. -
2026-04-15 Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A -
2026-04-15 Compliances-Reg.24(A)-Annual Secretarial Compliance -
2026-04-06 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-04-01 Reply To Clarification On Price Movement Sought By BSE Limited -
2026-03-30 Clarification sought from Star Source Multi Trade Ltd -
2026-03-30 Closure of Trading Window -
2026-02-16 Revised Outcome Of Board Meeting Held On February 12 2026 -
2026-02-13 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-02-12 Results For The Quarter And Nine Months Ended December 31 2025 -
2026-02-12 Board Meeting Outcome for Outcome Of Board Meeting For Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025 -